We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Mineralys Therapeutics
MLYS
$2.41B
| $253K | ﹤0.01% |
+16,134
| New | +$272K |
|
2902
OppFi
OPFI
$807M
| $251K | ﹤0.01% |
122,239
-2,999
| -2% | -$6.3K |
|
2903
Vanguard Morningstar Growth ETF
VUG
$231B
| $251K | ﹤0.01% |
+6,030
| New | +$235K |
|
|
AFMD
2904
DELISTED
Affimed
AFMD
| $248K | ﹤0.01% |
33,205
-287
| -0.9% | -$2.87K |
|
2905
Aemetis
AMTX
$120M
| $248K | ﹤0.01% |
107,072
-17,349
| -14% | -$64.6K |
|
2906
GeneDx Holdings
WGS
$2.31B
| $248K | ﹤0.01% |
20,554
+5,131
| +33% | +$68.4K |
|
|
CELL
2907
DELISTED
PhenomeX Inc. Common Stock
CELL
| $248K | ﹤0.01% |
214,012
-2,115
| -1% | -$3.87K |
|
|
ALPN
2908
DELISTED
Alpine Immune Sciences Inc
ALPN
| $245K | ﹤0.01% |
31,729
| – | – |
|
2909
Invivyd
IVVD
$212M
| $244K | ﹤0.01% |
203,878
+5,440
| +3% | +$9.93K |
|
2910
Superior Group of Companies
SGC
$223M
| $243K | ﹤0.01% |
30,823
-12,111
| -28% | -$130K |
|
|
MKFG
2911
DELISTED
Markforged Holding Corporation
MKFG
| $242K | ﹤0.01% |
25,221
-2,604
| -9% | -$32.4K |
|
|
AKYA
2912
DELISTED
Akoya BioSciences
AKYA
| $240K | ﹤0.01% |
29,374
-246
| -0.8% | -$2.57K |
|
2913
Plains All American Pipeline
PAA
$16.1B
| $240K | ﹤0.01% |
19,210
-307
| -2% | -$3.83K |
|
2914
PCB Bancorp
PCB
$391M
| $238K | ﹤0.01% |
16,442
| – | – |
|
2915
Red Violet
RDVT
$941M
| $236K | ﹤0.01% |
13,408
| – | – |
|
2916
Colony Bankcorp
CBAN
$467M
| $235K | ﹤0.01% |
23,042
-13,351
| -37% | -$162K |
|
|
RPTX
2917
DELISTED
Repare Therapeutics
RPTX
| $235K | ﹤0.01% |
23,846
+2,216
| +10% | +$25.4K |
|
|
ICVX
2918
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $235K | ﹤0.01% |
40,511
-14,310
| -26% | -$124K |
|
2919
First Bank
FRBA
$454M
| $233K | ﹤0.01% |
23,105
-11,964
| -34% | -$154K |
|
2920
NI Holdings
NODK
$324M
| $232K | ﹤0.01% |
17,869
-10,188
| -36% | -$136K |
|
2921
Concrete Pumping Holdings
BBCP
$491M
| $231K | ﹤0.01% |
33,946
-30
| -0.1% | -$218 |
|
2922
Hydrofarm Holdings
HYFM
$7.53M
| $230K | ﹤0.01% |
13,266
+1,182
| +10% | +$20.9K |
|
2923
Bank of America Series L
BAC.PRL
$3.99B
| – | – |
0
| – | – |
|
|
AC
2924
DELISTED
Associated Capital Group
AC
| $224K | ﹤0.01% |
6,059
-5,017
| -45% | -$187K |
|
|
JNCE
2925
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $223K | ﹤0.01% |
120,810
-10,575
| -8% | -$13.1K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.